Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine

H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …

The identification of novel biomarkers is required to improve adult SMA patient stratification, diagnosis and treatment

P Smeriglio, P Langard, G Querin, MG Biferi - Journal of personalized …, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is currently classified into five different subtypes, from the
most severe (type 0) to the mildest (type 4) depending on age at onset, best motor function …

[HTML][HTML] Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy

LE Marasco, G Dujardin, R Sousa-Luís, YH Liu… - Cell, 2022 - cell.com
Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations of the SMN1
gene. The human paralog SMN2, whose exon 7 (E7) is predominantly skipped, cannot …

[HTML][HTML] Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex

T Petrozziello, AN Mills, CA Vaine, EB Penney… - Neurobiology of …, 2020 - Elsevier
Neuroinflammation plays a pathogenic role in neurodegenerative diseases and recent
findings suggest that it may also be involved in X-linked Dystonia-Parkinsonism (XDP) …

[HTML][HTML] Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells

S Zhang, L Zhan, X Li, Z Yang, Y Luo… - International journal of …, 2021 - ncbi.nlm.nih.gov
Genetic changes are difficult to reverse; thus, epigenetic aberrations, including changes in
DNA methylation, histone modifications, and noncoding RNAs, with potential reversibility …

[HTML][HTML] Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges

US Haque, T Yokota - Genes, 2024 - mdpi.com
Spinal muscular atrophy (SMA) is a severe genetic disorder characterized by the loss of
motor neurons, leading to progressive muscle weakness, loss of mobility, and respiratory …

Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis

M Gavriilaki, M Moschou, V Papaliagkas, K Notas… - Neuromuscular …, 2022 - Elsevier
Since the introduction of disease modifying treatments there is an unmet need to identify
biomarkers of spinal muscular atrophy (SMA) natural history. We performed a systematic …

Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: An update

LG Di Pasqua, M Cagna, C Berardo, M Vairetti… - Biomedicines, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
some of the biggest public health challenges due to their spread and increasing incidence …

Molecular pathogenesis and new therapeutic dimensions for spinal muscular atrophy

A López-Cortés, G Echeverría-Garcés… - Biology, 2022 - mdpi.com
Simple Summary Globally, 5q spinal muscular atrophy (SMA) is one of the most common
pediatric autosomal recessive neuromuscular diseases, with a prevalence of~ 1–2 per …

[HTML][HTML] Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction

F Torri, M Mancuso, G Siciliano, G Ricci - International Journal of …, 2024 - mdpi.com
5q-Spinal muscular atrophy (5q-SMA) is one of the most common neuromuscular diseases
due to homozygous mutations in the SMN1 gene. This leads to a loss of function of the …